Sustainable Biz Magazine - Magazine - Page 34
Stevenage Bioscience Catalyst –
a hothouse for innovation
S
tevenage Bioscience Catalyst is
a leading location for companies
to develop and commercialise
cutting edge therapeutics. It is uniquely
well placed to drive innovation situated
at the heart of the golden research
triangle of London-Cambridge-Oxford.
The campus is home to GSK’s two main
global research and development
facilities, the Cell and Gene Therapy
Catapult Manufacturing Centre, LifeArc
and Stevenage Bioscience Catalyst. This
co-location of R&D and manufacturing
facilities enables companies to move
from start-up to scale up to the
development of potentially life-saving
therapeutics.
34
"The total private equity
investment in biotechnology
raised in Stevenage has grown
to become comparable with
that of Cambridge, London
and Oxford"
With over 160,000 sq ft of lab and office
space offered at highly competitive prices,
Stevenage Bioscience Catalyst is home to
a growing cluster of start-up companies
that together have raised £3bn to date.
The total private equity investment
S USTAI N AB L E B I Z MAGAZINE
NOVEMBER 2023
in biotechnology raised in Stevenage
has grown to become comparable with
that of Cambridge, London and Oxford,
securing Life Science Opportunity Zone
and High Potential Opportunity status
and contributing to the Government’s
ambition for the UK to become a ‘science
superpower’.
As demand for lab space outgrows supply,
the campus is expanding with planning
approval secured by UBS Management and
Reef Group (Reef) to create one of Europe’s
largest life science sites in Stevenage. The
£900m life science campus will provide
1.6 million sq. ft of lab, office and Good
Manufacturing Practices (GMP) facilities